(Q53863979)

English

Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial1

scientific article published on April 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial1 (English)

reason for preferred rank

most precise value

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698090

24 December 2023

Cytomegalovirus

0 references

lung transplant

1 reference

based on heuristic

inferred from title

10

object named as

Paolo Grossi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698090

24 December 2023

author name string

Giuseppe Gerna

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Fausto Baldanti

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Daniele Lilleri

3

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Maurizio Parea

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Maria Torsellini

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Barbara Castiglioni

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Patrizio Vitulo

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Carlo Pellegrini

8

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Mario Viganò

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Maria Grazia Revello

11

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

15 April 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12698090

24 December 2023

full work available at URL

https://journals.lww.com/transplantjournal/Fulltext/2003/04150/Human_cytomegalovirus_pp67_mRNAemia_versus_pp65.18.aspx

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12698090

24 December 2023

https://journals.lww.com/10.1097/01.TP.0000057239.32192.B9

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

75

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

1012-1019

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Prevention and treatment of cytomegalovirus infection in organ transplant recipients

1

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Prevention and treatment of cytomegalovirus disease in heart transplant patients

2

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Infection in organ-transplant recipients

3

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

4

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

6

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE

7

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection

9

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

10

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients

11

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients

13

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

14

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals

16

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Definitions of cytomegalovirus infection and disease in transplant recipients

17

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia

19

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes

20

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

21

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.

22

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Rapid and simple method for purification of nucleic acids

23

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Nonparametric Estimation from Incomplete Observations

24

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

25

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

26

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients.

27

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy

28

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors

29

1 reference

10.1097/01.TP.0000057239.32192.B9

https://api.crossref.org/works/10.1097/01.TP.0000057239.32192.B9

24 December 2023

Identifiers

10.1097/01.TP.0000057239.32192.B9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/12698090

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53863979&oldid=2036068211"